Metagenomi Therapeutics, Inc. (MGX)
NASDAQ: MGX · Real-Time Price · USD
1.480
-0.130 (-8.07%)
At close: Mar 6, 2026, 4:00 PM EST
1.490
+0.010 (0.68%)
After-hours: Mar 6, 2026, 7:06 PM EST
Metagenomi Therapeutics Employees
Metagenomi Therapeutics had 202 employees as of December 31, 2024. The number of employees decreased by 34 or -14.41% compared to the previous year.
Employees
202
Change (1Y)
-34
Growth (1Y)
-14.41%
Revenue / Employee
$203,306
Profits / Employee
-$708,613
Market Cap
55.57M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 202 | -34 | -14.41% |
| Dec 31, 2023 | 236 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| MindWalk Holdings | 102 |
| ImmuCell | 84 |
| BeyondSpring | 40 |
| Entera Bio | 22 |
| Edesa Biotech | 17 |
| Rallybio | 15 |
| Nutriband | 13 |
| Alterity Therapeutics | 9 |
MGX News
- 2 days ago - Metagenomi Therapeutics Reports Business Updates and Full Year 2025 Financial Results - GlobeNewsWire
- 3 days ago - Metagenomi Therapeutics, Inc. (MGX) Presents at TD Cowen 46th Annual Health Care Conference Transcript - Seeking Alpha
- 12 days ago - Metagenomi Therapeutics, Inc. to Present at the 46th Annual TD Cowen Healthcare Conference - GlobeNewsWire
- 7 weeks ago - Metagenomi Announces Corporate Name Change to Metagenomi Therapeutics, Inc. and Highlights Recent Business Milestones and 2026 Corporate Outlook - GlobeNewsWire
- 3 months ago - Metagenomi to Present Preclinical Data Supporting New Collaboration Target of APOC3 with Ionis Pharmaceuticals at Upcoming Nature Conference - GlobeNewsWire
- 3 months ago - Metagenomi to Present at Jefferies Global Healthcare Conference in London - GlobeNewsWire
- 4 months ago - Metagenomi Prioritizes Hemophilia A Program, Lays Off 25% Workforce - Benzinga
- 4 months ago - Metagenomi Reports Third Quarter 2025 Financial Results and Announces Strategic Pipeline Prioritization and Leadership Updates - GlobeNewsWire